HIVMA Honors Outstanding Achievements in HIV Clinical Education and Research With 2024 Awards
The HIV Medicine Association is pleased to recognize three members during IDWeek 2024 for their contributions to advancing the field of HIV medicine.
HIVMA Names Colleen Kelley, MD, MPH, FIDSA, Chair of the Board
The HIV Medicine Association is pleased to announce the election of Colleen Kelley, MD, MPH, FIDSA, as the new chair of its Board of Directors.
Senate Appropriations Bill Offers Lifeline for Key HIV-Related Programs, but Fails to Fund Important ID/HIV Workforce Program
The Senate bill also rejects the House proposal to split up the National Institute of Allergy and Infectious Diseases with significantly reduced funding.
House LHHS Appropriations Bill Harmful to HIV Response and ID Research
HIVMA is deeply concerned by the impact the House Labor, Health and Human Services, and Education bill would have on our ability to respond to the HIV epidemic and other infectious diseases.
IDSA and HIVMA Response to New CDC Guidelines on Doxycycline as Post-Exposure Prophylaxis
IDSA and HIVMA welcome the Centers for Disease Control and Prevention’s guidelines for implementing doxycycline as post-exposure prophylaxis, or doxy PEP, to prevent sexually transmitted infections.
IDSA and HIVMA Response to Uganda Court Decision on the Anti-Homosexuality Act
IDSA and HIVMA are disappointed and alarmed that Uganda’s Constitutional Court upheld the Anti-Homosexuality Act criminalizing LGBTQ individuals and their right to organize, educate and advocate.
HIVMA Urges Adoption of New Statin Therapy Recommendations for People With HIV
People with HIV have about a two-fold increased risk of cardiovascular disease and develop the disease about a decade earlier than the general population.
HIVMA Chair Applauds Appointment of Robyn Neblett Fanfair, MD, MPH, as Director of HIV Prevention at CDC
HIVMA is excited to congratulate Robyn Neblett Fanfair, MD, MPH, on her appointment as the permanent director of the Centers for Disease Control and Prevention’s Division of HIV Prevention.
IDSA & HIVMA on the Passing of ID & HIV Leader Adaora Adimora, MD, MPH, FIDSA
Dr. Adaora Adimora exemplified the difference a single person can make in the world. She was an extraordinary leader, infectious diseases physician, researcher, mentor, advocate and colleague committed to addressing the drivers of HIV-related health disparities with a special focus on women.
Response to Increase in Syphilis Cases in the United States
The dramatic increase in cases — 755% between 2012 and 2021 — represents missed opportunities in the health care system and the need for more resources at the local, state and federal levels.
HIVMA Recognizes Excellence in HIV Clinical Education and Research With 2023 Awards
The HIV Medicine Association is pleased to recognize three members during IDWeek 2023 for their contributions to advancing the field of HIV medicine.
HIVMA Names Allison Agwu Chair of its Board of Directors
The HIV Medicine Association is pleased to announce Allison Agwu, MD, ScM, FAAP, FIDSA, as its new chair. The Association also elected a new vice chair and named five new directors. HIVMA addresses health disparities and inequities in its mission to end the HIV epidemic.